Biogenic Silver–Selenium nanocomposite with anticancer activity and potent efficacy against vancomycin-resistant Staphylococcus aureus
Abeer S Aloufi, Mohammed S Abdulrahman, Amr H Hashem, Ebrahim Saied, Ahmed Abdel Tawab, Faisal Alsenani, Adnan Alharbi, Sami I Alzarea · 2026
Read Biogenic Silver–Selenium nanocomposite with anticancer activity and potent efficacy against vancomycin-resistant Staphylococcus aureus by Abeer S Aloufi, Mohammed S Abdulrahman, Amr H Hashem, Ebrahim Saied, Ahmed Abdel Tawab, Faisal Alsenani, Adnan Alharbi, Sami I Alzarea (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0351844.txt.
Description
Abeer Aloufi and seven co-authors present this 2026 PLOS One study of a silver-selenium particle mix. The mix was brewed with melon peel extract, a green way to make it. The team checked the blend's structure with several tools, and found mostly round particles. They tested it on cancer cells and on normal cells. They also tested it on clinical samples of a drug-resistant germ, a form of staph that shrugs off a key antibiotic.
The particles harmed two cancer cell lines at far lower doses than normal lung cells. That hints at selective toxicity. Against the resistant germs, the mix killed well and tore cell membranes. It also slowed biofilm growth, though results varied by strain. Mixing it with the old drug helped only at times. The authors present the blend as a promising dual-purpose candidate that needs more work.
Catalog record
| CREATOR | Abeer S Aloufi, Mohammed S Abdulrahman, Amr H Hashem, Ebrahim Saied, Ahmed Abdel Tawab, Faisal Alsenani, Adnan Alharbi, Sami I Alzarea |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 102646 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |